Diabetes Type 2 Clinical Trials

30 recruitingLast updated: June 18, 2026

There are 30 actively recruiting diabetes type 2 clinical trials across 19 countries. Studies span Not Applicable, Phase 3, Phase 1, Phase 2. Top locations include Herlev, Denmark, London, United Kingdom, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Diabetes Type 2 Trials at a Glance

30 actively recruiting trials for diabetes type 2 are listed on ClinicalTrialsFinder across 6 cities in 19 countries. The largest study group is Not Applicable with 19 trials, with the heaviest enrollment activity in Herlev, London, and Boston. Lead sponsors running diabetes type 2 studies include Attikon Hospital, Scripps Whittier Diabetes Institute, and Steno Diabetes Center Copenhagen.

Browse diabetes type 2 trials by phase

Treatments under study

About Diabetes Type 2 Clinical Trials

Looking for clinical trials for Diabetes Type 2? There are currently 32 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Diabetes Type 2 trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Diabetes Type 2 clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 30 trials

Recruiting
Not Applicable

Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life

Diabetes Type 2Overweight or Obesity
Yale University20 enrolled1 locationNCT07376655
Recruiting
Not Applicable

Dulce Digital 2.0 - Innovative Diabetes Self-Management in the Digital Age

Diabetes Type 2
Scripps Whittier Diabetes Institute150 enrolled2 locationsNCT05416060
Recruiting
Not Applicable

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

Diabetes MellitusDiabetes Mellitus, Type 2Diabetes+8 more
University of Colorado, Denver240 enrolled2 locationsNCT07011147
Recruiting

Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity

Dry Eye Disease (DED)Diabetes Type 2Diabete Mellitus+3 more
Attikon Hospital100 enrolled1 locationNCT07605572
Recruiting
Not Applicable

Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes

DiabetesDiabetes Type 2
University of Wisconsin, Madison376 enrolled1 locationNCT05912647
Recruiting
Phase 3

A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)

ObesityOverweightType 2 Diabetes+2 more
Pfizer999 enrolled183 locationsNCT07400653
Recruiting
Not Applicable

Continuous Glucose Monitoring (CGM) in an Underserved Population

Diabetes MellitusDiabetesDiabetes Type 2
Tulane University50 enrolled1 locationNCT07135531
Recruiting
Phase 2Phase 3

Canagliflozin Targeting Vascular Inflammation

Coronary Artery DiseaseDiabetes Type 2
Ottawa Heart Institute Research Corporation24 enrolled1 locationNCT05427084
Recruiting

Pregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes

Diabetes Type 2Gestational Diabetes Mellitus (GDM)Breastfeeding Continuation+1 more
University of California, Davis10 enrolled1 locationNCT07176793
Recruiting
Not Applicable

Digital Support for Reducing Salt Intake Among Patients With Diabetic Kidney Disease: Protocol for a Controlled Clinical Trial

Kidney DiseaseDiabetes Type 2
Steno Diabetes Center Copenhagen104 enrolled2 locationsNCT07485075
Recruiting
Not Applicable

Enhancing Digitally Delivered Diabetes Education With Real-Time CGM

Diabetes Type 2
Scripps Whittier Diabetes Institute140 enrolled1 locationNCT06296550
Recruiting

Disentangling the Effect of Brain Insulin Resistance on Brain Health

Diabetes Type 2Diabetes Type 1
Henrik Bo Wiberg Larsson150 enrolled3 locationsNCT07374705
Recruiting
Not Applicable

Comparative Effectiveness of Prescribed Adapted Physical Activity (APA), Either Practiced Independently After Training, or Supervised by an APA Teacher, on Glycemic Regulation in People With Unbalanced Type 2 Diabetes.

Diabetes Type 2Non-Insulin DependentPoorly Controlled Diabetes Mellitus
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète120 enrolled1 locationNCT06598865
Recruiting
Not Applicable

FELLAShip to Better Health

Obesity, OverweightHigh Blood GlucoseHigh Cholesterol+3 more
University of Alabama at Birmingham90 enrolled1 locationNCT07220213
Recruiting
Not Applicable

Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors

Type II Diabetes MellitusDiabetes Type 2
HealthNet Transcultural Psychosocial Organization250 enrolled1 locationNCT07350694
Recruiting
Not Applicable

Magnetic Compression Anastomosis Procedure for Partial Jejuno-ileal Diversion: Evaluating the Feasibility of a Novel Endoscopic Magnetic Metabolic Interventional Therapy

Bariatric SurgeryDiabetes Type 2
iIDEAS Group Holdings Limited5 enrolled1 locationNCT07350967
Recruiting
Not Applicable

Connected Care for Type 2 Diabetes Self-Management

Diabetes Type 2
Marche Region Regional Health Agency388 enrolled13 locationsNCT07149610
Recruiting

Medically Intensive Nutrition Therapy Program for Obesity and Diabetes in a Low-income Population

ObesityOverweightPrediabetes+1 more
Massachusetts General Hospital20 enrolled1 locationNCT05799222
Recruiting
Not Applicable

Pilot of Continuous Glucose Monitor-Augmented Food Is Medicine

Type 2 DiabetesDiabetes Type 2Nutrition+4 more
University of North Carolina, Chapel Hill60 enrolled1 locationNCT07148713
Recruiting
Not Applicable

Healthy Living Anson Study

CancerHypertensionHeart Disease+3 more
University of North Carolina, Chapel Hill120 enrolled1 locationNCT07126587